Aristippos Gennadios, President Softgel & Oral Technology at Catalent, Inc. (CTLT), sold 22,255 shares at $73.00 ($1.6M) on 2020-06-25, disclosed to the SEC on 2020-06-29.
Open-market sale of $1.6M CTLT by President Softgel & Oral Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.00 | 6,891 | $503K | 31.0% |
| 2 | $73.00 | 7,039 | $514K | 31.6% |
| 3 | $73.00 | 8,325 | $608K | 37.4% |
| Total | $73.00 avg | 22,255 | $1.6M | 100% |
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |